Published in Eur Heart J on May 01, 1999
Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes (2011) 1.49
Temporal trends in the use of intraaortic balloon pump associated with percutaneous coronary intervention in the United States, 1998-2008. Am Heart J (2014) 1.42
Intra-aortic balloon pump may grant no benefit to improve the mortality of patients with acute myocardial infarction in short and long term: an updated meta-analysis. Medicine (Baltimore) (2015) 0.88
Myocardial infarction, urgent angioplasty and intra-arterial balloon counterpulsation. Eur Heart J (1999) 0.79
Effects of intra-aortic balloon counterpulsation pump on mortality of acute myocardial infarction. PLoS One (2014) 0.79
Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics. Anesth Analg (2011) 0.76
The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review. BMC Cardiovasc Disord (2016) 0.75
The outcomes of intra-aortic balloon pump usage in patients with acute myocardial infarction: a comprehensive meta-analysis of 33 clinical trials and 18,889 patients. Patient Prefer Adherence (2016) 0.75
Perioperative intra-aortic balloon counterpulsation in a patient with myocardium at risk undergoing urgent noncardiac surgery. Ann Card Anaesth (2015) 0.75
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med (1993) 4.49
Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med (1999) 3.81
Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation (1998) 3.70
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation (2001) 3.03
Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J (2002) 2.98
Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction. Heart (1997) 2.93
Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart (1999) 2.40
Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv (2008) 2.12
[Acute myocardial infarct? Open the blood vessel involved]. Ned Tijdschr Geneeskd (1993) 2.06
Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation. Eur Heart J (2003) 1.97
Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation (1998) 1.87
Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol (1998) 1.77
Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet (1997) 1.77
Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris. Eur Heart J (1990) 1.74
Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J (2001) 1.71
Out-of-hospital ventricular fibrillation in patients with acute myocardial infarction: coronary angiographic determinants. J Am Coll Cardiol (2000) 1.61
Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. Eur Heart J (1995) 1.60
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol (1986) 1.57
Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol (1997) 1.57
Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J (1996) 1.54
Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM (2006) 1.53
Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J (2004) 1.48
Incidence, predictors, and outcome of reinfarction and stent thrombosis within one year after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2009) 1.45
[Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure]. Ned Tijdschr Geneeskd (2007) 1.45
Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group. Circulation (1995) 1.44
Limitation of myocardial infarct size after primary angioplasty: is a higher patency the only mechanism? Am Heart J (1999) 1.43
High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study. J Am Coll Cardiol (1998) 1.42
Assessment of coronary artery bypass graft patency by multidetector computed tomography and electron-beam tomography. Int J Cardiovasc Imaging (2005) 1.40
Long-term clinical outcome of patients with diabetes proposed for coronary revascularisation. Neth J Med (2006) 1.39
Ticlopidine and renal function. Lancet (1996) 1.39
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation (1996) 1.39
[Multidetector computed tomography of the coronary arteries]. Ned Tijdschr Geneeskd (2004) 1.38
Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation (1991) 1.35
Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation (1994) 1.32
Glycosylated haemoglobin in renal failure. Diabetologia (1980) 1.30
Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol (1994) 1.30
Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention. Neth Heart J (2008) 1.29
Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators. J Am Coll Cardiol (1999) 1.27
Restenosis after coronary angioplasty: the paradox of increased lumen diameter and restenosis. J Am Coll Cardiol (1992) 1.23
The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol (2001) 1.16
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J (2008) 1.16
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group. J Am Coll Cardiol (1996) 1.13
Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J (2003) 1.12
Calcium scoring using 64-slice MDCT, dual source CT and EBT: a comparative phantom study. Int J Cardiovasc Imaging (2007) 1.10
Predictive value of reactive hyperemic response on reperfusion on recovery of regional myocardial function after coronary angioplasty in acute myocardial infarction. Circulation (1994) 1.09
Effect of gender difference on platelet reactivity. Neth Heart J (2011) 1.09
Major achievements in cardiology in the past century: influence on Dutch cardiovascular medicine. Neth Heart J (2009) 1.07
Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome. Neth Heart J (2007) 1.07
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J (1999) 1.07
A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol (1995) 1.05
Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location. Heart (2005) 1.04
Quantification of global left ventricular function: comparison of multidetector computed tomography and magnetic resonance imaging. a meta-analysis and review of the current literature. Acta Radiol (2006) 1.04
Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome. J Thromb Haemost (2010) 1.01
Percutaneous transluminal angioplasty of a totally occluded venous bypass graft: a challenge that should be resisted. Am J Cardiol (1989) 1.01